Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment

Journal of Rheumatology

Volumn 30, Issue 10, 2003, Pages 2140-2146

  Vera Lastra, Olga ^b   Mendez, Carmen ^c   Jara, Luis J ^c   Cisneros, Martín ^c   Medina, Gabriela ^c   Ariza, Raul ^a   Espinoza, Luis R ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c NONE

Author keywords

Prolactin; Systemic lupus erythematosus activity; Systemic lupus erythematosus disease activity index

Indexed keywords

CHLOROQUINE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISONE; PROLACTIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; HYPERPROLACTINEMIA; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNORADIOMETRIC ASSAY; IMMUNOSUPPRESSIVE TREATMENT; PATHOGENESIS; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCORING SYSTEM; SLEDAI SCORE; SYSTEMIC LUPUS ERYTHEMATOSUS; TIME SERIES ANALYSIS;

ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROLACTIN; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0141531081     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RM. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocrin Rev 1996;17:639-69.
2. Berczi I, Nagy E. The effect of prolactin and growth hormone on hemolymphopoietic tissue and immune function. In: Berczi I, Kovacs K, editors. Hormones and immunity. Lancaster: MTP Press; 1987:145.
3. McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 1991;147:3780-7.
4. Walker SE, Jacobson JD. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum Dis Clin North Am 2000;26:713-36.
5. Jara LJ, Gomez-Sanchez C, Silveira LH, Martinez-Osuna P, Vasey FB, Espinoza LR. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci 1992;303:222-6.
6. Neidhart M. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 1996;23:476-81.
7. Allen SH, Sharp GC, Wang G, et al. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus 1996;5:30-7.
8. Pauzner R, Urowitz MB, Gladman DD, Cough JM. Prolactin in systemic lupus erythematosus. J Rheumatol 1994;21:2064-7.
9. Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 1996;23:629-32.
10. Ostendorf B, Fischer R, Santen R, Schmitz-Linneweber B, Specker C, Scheneider M. Hyperprolactinemia in systemic lupus erythematosus? Scand J Rheumatol 1996;25:97-102.
11. Mok CC, Lau CS. Lack of association between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 1996;23:2185-6.
12. Tolis G, Goldstein M, Friesen HG. Functional evaluation on prolactin secretion in patients with hypothalamic-pituitary disorders. J Clin Invest 1973;52:783-8.
13. Stuart MC, Underwood PA, Boscato L. A monoclonal antibody suitable for the radioimmunoassay for human prolactin. J Clin Endocrinol Metab 1984;54:881-4.
14. Jara LJ, Vera-Lastra O, Miranda JM, Alcala M, Alvarez-Nemegyei J. Prolactin in human systemic lupus erythematosus. Lupus 2001;10:748-56.
15. Blanco-Favela F, Quintal-Alvarez G, Leaños-Miranda A. Association between prolactin and the activity in systemic lupus erythematosus. Influence of statistical power. J Rheumatol 1999;26:55-9.
16. Leanos A, Pascoe D, Fraga A, Blanco-Favela F. Anti-PRL antibodies in systemic lupus erythematosus patients with associated hyperprolactinemia. Lupus 1998;7:398-403.
17. Miranda JM, Prieto RE, Paniagua R, et al. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. Lupus 1998;7:387-91.
18. Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza LR. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol 1998;17:110-4.
19. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
20. Bombardier C, Gladman DD, Urowitz MD, Caron D, Chang CH, and The Committee on Prognosis Studies in SLE. Derivation of the SLEDAI, a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
21. Vance LM, Thorner MO. Prolactin: hyperprolactinemic syndromes and management. In: DeGroot LJ, editor. Endocrinology. Philadelphia: WB Saunders; 1989:408-18.
22. Ferreira C, Paes M, Gouveia A, Ferreira E, Padua F, Fiuza T. Plasma homovanillic acid and prolactin in systemic lupus erythematosus. Lupus 1998;7:383-6.
23. Scali JJ, Barcena P, Visentini S, Salomon J, Morales E. Hyperprolactinemia, uveitis, and systemic lupus erythematosus: clinical-immunological correlation. Ann NY Acad Sci 1999;22:378-82.
24. Mok CC, Lau CS, Tam SC. Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients. Br J Rheumatol 1997;36:986-9.
25. Folomeev M, Prokaeva T, Nassonova V, Nassonov E, Masenko V, Ovtraht N. Prolactin levels in males with SLE and RA. J Rheumatol 1990;17:1569-70.
26. Jara-Quezada L, Graef A, Lavalle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol 1991;18:349-53.
27. Petri M, Chan D. Longitudinal analysis of prolactin and disease activity in SLE [abstract]. Arthritis Rheum 1995;38 Suppl:S220.
28. McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol 1994;21:843-50.
29. Zoli A, Ferlisi EM, Pompa A, et al. Basal and after stimuli test for prolactinemia in systemic lupus erythematosus. Ann NY Acad Sci 1999;876:155-8.
30. El-Garf A, Salah S, Shaarawy M, Saaki S, Anwer S. Prolactin hormone in juvenile systemic lupus erythematosus: A possible relationship to disease activity and CNS manifestations. J Rheumatol 1996;23:374-7.
31. Rovensky J, Jurankova E, Rauova L, et al. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus. J Rheumatol 1997;24:2330-4.
32. Jimena P, Aguirre MA, Lopez-Cuberlo A, de Andres M, Garcia-Courtay C, Cuadrado MJ. Prolactin levels in patients with systemic lupus erythematosus: a case controlled study. Lupus 1998;7:383-6.
33. Tansey MJ, Schlechte JA. Pituitary production of prolactin and prolactin-suppressing drugs. Lupus 2001;10:660-4.
34. Stryker TD, Molich ME. Reversible hyperthyrotropinemia, hyperthyroxinemia and hyperprolactinemia due to adrenal insufficiency. Am J Med 1985;79:271-4.
35. Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, Sosa-Muñoz J, Miranda JM, Jara LJ. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo controlled study. Lupus 1998;7:414-9.
36. Hrycek A, Cieslik P, Tustanowski J, Nowak S, Jedynak P. Selected serum cytokines in systemic lupus erythematosus treated with quinagolide. Lupus 2001;10:424-30.
37. McMurray RW. Bromocriptine in rheumatic and autoimmune diseases. Semin Arthritis Rheum 2001;31:21-32.
38. Lavalle C, Loyo E, Paniagua R, et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 1987;14:268-72.
39. Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 2001;10:554-61.
40. Pacilio M, Migliaresi S, Meli R, Ambrosono L, Bigliardo B, Di Carlo R. Elevated bioactive levels in systemic lupus erythematosus - Association with disease activity. J Rheumatol 2001;28:2216-21.
41. Leanos-Miranda A, Pascoe-Lira D, Chavez-Rueda K, Blanco-Favela F. Antiprolactin autoantibodies in systemic lupus erythematosus: Frequency and correlation with prolactinemia and disease activity. J Rheumatol 2001;28:1546-53.
42. Funauchi M, Ikoma S, Enomoto H, et al. Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma. Clin Exp Rheumatol 1998;16:479-82.
43. Jara LJ, Prasad C, Espinoza LR. Elevated serum levels of ciclo (His-Pro), an endogenous inhibitor of pituitary prolactin secretion, in systemic lupus erythematosus patients. Lupus 1997;6:258-60.
44. Gutierrez MA, Molina JF, Jara LJ, et al. Prolactin and systemic lupus erythematosus: Prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus 1995;4:348-52.
45. Larrea F, Martinez-Castillo A, Cabrera V, et al. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J Clin Endocrinol Metab 1997;82:3664-9.
46. Montgomery DW. Prolactin production by immune cells. Lupus 2001;10:665-75.
47. Stevens A, Ray DW, Worthington J, Davis JRE. Polymorphisms of the human prolactin gene - implications for production of lymphocyte prolactin and systemic lupus erythematosus. Lupus 2001;10:676-83.
48. Nagafuchi H, Suzuki N, Kaneko A, Asai T, Sakane T. Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol 1999;26:1890-900.
49. Nagy E, Berczi I. Hypophysectomized rats depend on residual prolactin for survival. Endocrinology 1991;128:2776-84.
50. Peeva E, Michael D, Cleary J, Rice J, Chen X, Diamond B. Prolactin modulates the naive B cell repertoire. J Clin Invest 2003;111:275-83.
51. Gellersen B, DiMattia GE, Friesen HG. Regulation of prolactin secretion in the human B-lymphoblastoid cell line IM-9-P3 by dexamethasone but not other regulators of pituitary prolactin secretion. Endocrinology 1989;125:2853-61.
52. Rheem GH, Ray DW, Davis JRE. The human prolactin gene upstream promoter is regulated in lymphoid cells by activators of T-cells and by cAMP. J Mol Endocrinol 1999;22:285-93.